Switching to RPV/FTC/TAF From RPV/FTC/TDF or EFV/FTC/TDF Switching to RPV/FTC/TAF From RPV/FTC/TDF or EFV/FTC/TDF

Switching to a coformulated regimen containing tenofovir alafenamide may provide additional bone and renal benefits in HIV patients.HIV Medicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news
More News: Health | HIV AIDS | Viread